Table 2. Adverse events associated with treatment.
Chemotherapy | Chemotherapy plus icotinib | |||
---|---|---|---|---|
(n = 18) | (n = 21) | |||
n (%) | n (%) | |||
Grade 1 | Grade 2 | Grade 1 | Grade 2 | |
Gastrointestinal reactions | 3 (16.7%) | 1 (5.6%) | 3 (14.3%) | 0 |
Marrow suppression | 3 (16.7%) | 0 (0.0%) | 4 (19.0%) | 0 |
Neurotoxicity | 3 (16.7%) | 1 (5.6%) | 4 (19.0%) | 0 |
Liver and kidney damage | 2 (11.1%) | 1 (5.6%) | 4 (19.0%) | 0 |
Allergic reactions | 2 (11.1%) | 1 (5.6%) | 3 (14.3%) | 0 |